Legato Capital Management LLC decreased its holdings in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 48.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,392 shares of the technology company’s stock after selling 2,290 shares during the quarter. Legato Capital Management LLC’s holdings in Plexus were worth $352,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in PLXS. Covestor Ltd boosted its position in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after acquiring an additional 162 shares during the period. Allworth Financial LP boosted its position in shares of Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after acquiring an additional 103 shares during the period. Johnson Financial Group Inc. bought a new stake in shares of Plexus in the third quarter valued at about $72,000. Farther Finance Advisors LLC boosted its position in shares of Plexus by 114.7% in the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock valued at $75,000 after acquiring an additional 273 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after acquiring an additional 490 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.
Plexus Stock Down 1.7%
PLXS stock opened at $268.26 on Thursday. The company has a market cap of $7.18 billion, a PE ratio of 39.22 and a beta of 0.88. The business has a 50-day simple moving average of $234.90 and a 200 day simple moving average of $193.15. Plexus Corp. has a 52 week low of $115.35 and a 52 week high of $275.83. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on PLXS shares. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Needham & Company LLC boosted their target price on shares of Plexus from $206.00 to $285.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Benchmark reissued a “buy” rating and issued a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Zacks Research cut shares of Plexus from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 20th. Finally, Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $234.17.
Get Our Latest Research Report on Plexus
Insider Buying and Selling
In related news, CEO Todd P. Kelsey sold 3,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $268.45, for a total value of $805,350.00. Following the completion of the transaction, the chief executive officer owned 74,888 shares of the company’s stock, valued at $20,103,683.60. The trade was a 3.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $195.59, for a total value of $97,795.00. Following the completion of the transaction, the director directly owned 8,535 shares of the company’s stock, valued at approximately $1,669,360.65. This trade represents a 5.53% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 19,971 shares of company stock worth $5,098,446 in the last ninety days. 1.78% of the stock is owned by company insiders.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
